CORAMITUG
UNII 1D57NC901Z

Substance Identification & Data

This profile provides standardized clinical and technical data for Coramitug, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 1D57NC901Z.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2626841-92-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

1D57NC901Z

CAS Registry Number

2626841-92-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

CORAMITUG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C203146

National Cancer Institute reference terminology for clinical and research data.

INN ID

12646

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

NO-66

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Coramitug. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CORAMITUG

Common Names & Synonyms

CORAMITUG [INN]

CORAMITUG [USAN]

CORAMITUG [WHO-DD]

GAMMA1 HEAVY CHAIN (1-454) (VH (MUS MUSCULUS IGHV5-12-2*01 (92.9%) -(IGHD) -IGHJ4*01 (84.6%) S123>L (119), CDR-IMGT (8.8.17) (26-33.51-58.97-113)) (1-124) -HOMO SAPIENS IGHG1*03 (100%), G1M3, NG1M1CH1 R120, E12, M14 (CH1 R120 (221)(125-222), HINGE 1-15 (223-237), CH2 (238-347), CH3 E12 (363), M14 (365) (348-452), CHS (453-454)) (125-454)), (227-219')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-219') (V-KAPPA (MUS MUSCULUS IGKV2-137*01(89.0%) -IGKJ2*03 (90.9%) S120>Q (105'), CDR-IMGT (11.3.9) (27'-37'.55'-57'.94'-102')) (1'-112') -HOMO SAPIENS IGKC*01 (100%), KM3, A45.1 (158'),V101 (196') (113'-219')); DIMER (233-233'':236-236'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-DG44, GLYCOFORM ALFA

IMMUNOGLOBULIN G1, ANTI-(HUMAN TRANSTHYRETIN) (HUMAN-MUS MUSCULUS MONOCLONAL PRX004 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL PRX004 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TTR (TRANSTHYRETIN) MISFOLDED), MONOCLONAL ANTIBODY

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TTR (TRANSTHYRETIN) MISFOLDED), MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN (1-454) (VH (MUS MUSCULUS IGHV5-12-2*01 (92.9%) -(IGHD) -IGHJ4*01 (84.6%) S123>L (119), CDR-IMGT (8.8.17) (26-33.51-58.97-113)) (1-124) -HOMO SAPIENS IGHG1*03 (100%), G1M3, NG1M1CH1 R120, E12, M14 (CH1 R120 (221) (125-222), HINGE 1-15 (223-237), CH2 (238-347), CH3 E12 (363), M14 (365) (348-452), CHS (453-454)) (125-454)), (227-219')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-219') (V-KAPPA (MUS MUSCULUS IGKV2-137*01 (89.0%) -IGKJ2*03 (90.9%) S120>Q (105'), CDRIMGT (11.3.9) (27'-37'.55'-57'.94'-102')) (1'-112') - HOMO SAPIENS IGKC*01 (100%), KM3, A45.1 (158'), V101 (196') (113'-219')); DIMER (233-233'':236-236'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-DG44, GLYCOFORM ALFA